Top Story

VIDEO: Physicians have ‘3 main opportunities’ to reduce colorectal cancer in younger patients

February 10, 2016

As the prevalence of colorectal cancer rises “slowly and steadily” among patients under the age of 50 years, clinicians have three major opportunities to reduce the disease in this population, according to Matthew Kalady, MD, a colorectal surgeon at Cleveland Clinic.

Hereditary cancer foundation launches Lynch Syndrome patient registry

February 10, 2016
AliveAndKickn has announced the launch of the HEROIC Registry, a genetic database for people with Lynch Syndrome to share data and further research, according to a press…
In the Journals

Obesity linked to poor outcomes in acute promyelocytic leukemia

February 10, 2016
Obesity appeared significantly associated with shorter DFS and OS among adult patients with acute promyelocytic leukemia, according to a pooled analysis of four clinical…
FDA News

FDA places full clinical hold on pacritinib

February 10, 2016
The FDA has placed a full clinical hold on studies that involve pacritinib, an oral tyrosine kinase inhibitor in development for the treatment of patients with…
In the Journals

Palliative care reduces financial burden of patients with advanced cancer, comorbidities

February 10, 2016
The immediate initiation of palliative care among hospitalized patients with incurable cancers and chronic comorbid conditions resulted in significant hospital cost…
More News Headlines »

The Patient with Lymphadenopathy

No commercial support for this activity.

Castleman’s disease is a rare lymphoproliferative disorder that is characterized by enlargement of 1 (unicentric) or…
More »
Meeting News CoverageVideo

VIDEO: Novel prediction model accurately determines survival in gastric cancer

February 5, 2016
More »

Optimizing the Management of Metastatic Melanoma: Clinical Insights for Selecting First-line Therapy

This activity is supported by an independent educational grant from Merck & Co., Inc.

The incidence of melanoma is continuing to increase worldwide. In recent years, the treatment landscape for this…
More »
Current Issues
View the Current Issue
HemOnc Today